Poliovirus infection
MONDO:0024618An disease or disorder caused by infection with Enterovirus C.
Also known as: Enterovirus C caused disease or disorder, Enterovirus C disease or disorder, Enterovirus C infectious disease, human poliovirus infection, infection caused by human poliovirus
42 clinical trials for this condition and its sub-types, 0 tagged with Poliovirus infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Poliovirus infection
-
Poliomyelitis 28 trials · 39 incl. sub-types
3 sub-types
- Postpoliomyelitis syndrome 11 trials
- Acute nonparalytic poliomyelitis 0 trials
- Paralytic poliomyelitis 0 trials Sub-types →
-
Meningitis caused by poliovirus 0 trials
Most studied deeper sub-types
-
Can a Birth-Dose polio vaccine block the virus in Babies' guts?
Vaccine Recruiting nowResearchers are testing whether a new oral polio vaccine called nOPV2, given at birth, helps infants block type 2 poliovirus in their intestines. The trial enrolls 740 healthy newborns who have received standard injected polio vaccines. Scientists will check stool samples for sig…
Phase 3 • Sponsor: Fidec Corporation • Aim: Vaccine
Last updated Sep 11, 2026 00:00 UTC
-
New polio vaccine trial aims to protect the youngest
Vaccine Recruiting nowThis study tests a new oral polio vaccine (nOPV3) in healthy young children, infants, and newborns in Panama. The goal is to see if it is safe and triggers a strong immune response compared to the current vaccine. About 1,500 participants will receive either the new or existing v…
Phase 2 • Sponsor: PATH • Aim: Vaccine
Last updated Jun 27, 2026 12:31 UTC
-
Polio vaccine showdown: which sequence protects best?
Vaccine Recruiting nowThis study tests two types of inactivated polio vaccine (Sabin strain and wild strain) given in different orders to 480 infants aged 2 months. The goal is to see which sequence triggers the best immune response and causes the fewest side effects. Participants will receive three d…
Phase 4 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 11:00 UTC
-
One polio shot enough? new trial tests simpler vaccine schedule
Vaccine Recruiting nowThis phase 4 study compares a single dose of an inactivated polio vaccine (sIPV) in people aged 7 to 50 years with the standard three-dose series given to infants. Researchers want to see if one shot can produce a similar immune response. The trial is recruiting 180 healthy parti…
Phase 4 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 08:12 UTC
-
New polio vaccine trial aims to boost eradication efforts
Vaccine Recruiting nowThis study tests a new oral polio vaccine (nOPV1) in over 2,200 healthy young children, infants, and newborns in Bangladesh. Researchers will compare it to the current Sabin vaccine to see if it is safe and triggers a strong immune response. The goal is to find a more stable vacc…
Phase 2 • Sponsor: PATH • Aim: Vaccine
Last updated Jun 27, 2026 08:09 UTC
-
New polio vaccine combo tested in infants: could speed up eradication
Vaccine Recruiting nowThis study tests whether giving two new oral polio vaccines (types 1 and 2) together is safe and works as well as giving them separately in healthy 16-week-old infants. About 675 babies in Panama will receive either the combo or single vaccines. The goal is to see if the combo ap…
Phase 2 • Sponsor: PATH • Aim: Vaccine
Last updated Jun 27, 2026 08:09 UTC
-
Supercharged donor cells take on viruses after transplant
Disease control Recruiting nowThis study tests whether specially grown donor immune cells (viral-specific T-cells) can safely treat viral infections that often occur after a stem cell transplant. These infections can be serious and sometimes don't respond to standard antiviral drugs. The approach aims to boos…
Phase 1/2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can donor cells stop viruses after transplant?
Disease control Recruiting nowThis study tests whether giving patients donor-derived immune cells (VSTs) on a regular schedule can prevent dangerous viral infections after a stem cell transplant. 180 participants will be randomly assigned to receive VSTs either on a fixed schedule or only when a virus is dete…
Phase 2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New powered brace aims to restore mobility for leg weakness patients
Symptom relief Recruiting nowThis study tests a powered leg brace called the Nomad in 36 people who have trouble walking due to conditions like stroke, multiple sclerosis, or spinal cord injury. Participants will use the brace at home for three months to see if it improves their walking speed, balance, and q…
Sponsor: Shirley Ryan AbilityLab • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Shocking muscles to move: new exercise hope for nerve disease patients
Symptom relief Recruiting nowThis study tests whether whole-body electrical muscle stimulation (WB-EMS) can help adults with neuromuscular diseases like ALS, SMA, and muscular dystrophy exercise safely. Because these conditions weaken the nerves that control muscles, traditional exercise is often too hard. W…
Sponsor: University of Missouri-Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Swiss study tracks childhood cancer Survivors' health for decades
Knowledge-focused Recruiting nowThis study follows 3,000 childhood cancer survivors in Switzerland to learn about long-term health problems caused by cancer treatments. Participants undergo physical exams, lab tests, and questionnaires during regular follow-up visits. The goal is to better understand and manage…
Sponsor: University of Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC